Hepatitis G Virus or GBV-C: A Natural Anti-HIV Interfering Virus

[1]  A. López-Guillermo,et al.  Hepatitis C virus and GBV‐C virus prevalence among patients with B‐cell lymphoma in different European regions: a case‐control study of the International Extranodal Lymphoma Study Group , 2012, Hematological oncology.

[2]  C. Jopling,et al.  Liver-specific microRNA-122 , 2012, RNA biology.

[3]  O. Bagasra,et al.  Potential utility of GB virus type C as a preventive vaccine for HIV-1 , 2012, Expert review of vaccines.

[4]  I. Haro,et al.  Biophysical investigations of GBV-C E1 peptides as potential inhibitors of HIV-1 fusion peptide. , 2011, Chemphyschem : a European journal of chemical physics and physical chemistry.

[5]  Christopher J. Miller,et al.  TRIM5α Does Not Affect Simian Immunodeficiency Virus SIVmac251 Replication in Vaccinated or Unvaccinated Indian Rhesus Macaques following Intrarectal Challenge Exposure , 2011, Journal of Virology.

[6]  K. Kidd,et al.  The molecular origin and consequences of escape from miRNA regulation by HLA-C alleles. , 2011, American journal of human genetics.

[7]  B. Cowie,et al.  Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease. , 2011, Journal of hepatology.

[8]  I. Haro,et al.  Effect of E1(64-81) hepatitis G peptide on the in vitro interaction of HIV-1 fusion peptide with membrane models. , 2011, Biochimica et biophysica acta.

[9]  G. Silvestri,et al.  Generalized immune activation and innate immune responses in simian immunodeficiency virus infection. , 2011, Current opinion in HIV and AIDS.

[10]  H. Tillmann,et al.  Diagnostic Value of Anti‐GBV‐C Antibodies in HIV‐Infected Patients , 2011, Chemical biology & drug design.

[11]  H. Wedemeyer,et al.  No increased incidence for GB‐virus C infection in a cohort of HIV‐positive lymphoma patients , 2011, International journal of cancer.

[12]  Ò. Domènech,et al.  Study of the inhibition capacity of an 18-mer peptide domain of GBV-C virus on gp41-FP HIV-1 activity. , 2011, Biochimica et biophysica acta.

[13]  B. Fleckenstein,et al.  Peptides Derived from a Distinct Region of GB Virus C Glycoprotein E2 Mediate Strain-Specific HIV-1 Entry Inhibition , 2011, Journal of Virology.

[14]  Y. Maehara,et al.  Clinical significance and potential of hepatic microRNA‐122 expression in hepatitis C , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[15]  J. Levi,et al.  Influence of hepatitis G virus (GB virus C) on the prognosis of HIV-infected women , 2011, International journal of STD & AIDS.

[16]  E. Shankar,et al.  Current Views on the Pathophysiology of GB Virus C Coinfection with HIV-1 Infection , 2011, Current infectious disease reports.

[17]  R. A. Odeh.  RETRACTED: Detection and genotyping of GB virus-C in dromedary camels in the United Arab Emirates , 2011 .

[18]  J. McLinden,et al.  The natural history of non-human GB virus C in captive chimpanzees , 2011, The Journal of general virology.

[19]  Jack T Stapleton,et al.  The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation , 2010, Science.

[20]  O. Bagasra,et al.  Triplex-forming MicroRNAs Form Stable Complexes With HIV-1 Provirus and Inhibit its Replication , 2010, Applied immunohistochemistry & molecular morphology : AIMM.

[21]  A. Willis,et al.  Translation deregulation in B-cell lymphomas. , 2010, Biochemical Society transactions.

[22]  Xin Li,et al.  Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. , 2010, Antiviral research.

[23]  D. Montefiori,et al.  GB Virus Type C Envelope Protein E2 Elicits Antibodies That React with a Cellular Antigen on HIV-1 Particles and Neutralize Diverse HIV-1 Isolates , 2010, The Journal of Immunology.

[24]  S. Pfeffer,et al.  Impact of microRNAs for pathogenesis and treatment of hepatitis C virus infection. , 2010, Gastroenterologie clinique et biologique.

[25]  Lipeng Qiu,et al.  miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV. , 2010, Biochemical and biophysical research communications.

[26]  C. Gil,et al.  Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection. , 2010, Journal of medicinal chemistry.

[27]  T. Kawamata,et al.  miRNAs in normal and malignant B cells , 2010, International journal of hematology.

[28]  B. Clotet,et al.  GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4+ T-cells , 2010, Antiviral therapy.

[29]  R. Gascoyne,et al.  GBV‐C/hepatitis G virus infection and non‐Hodgkin lymphoma: a case control study , 2010, International journal of cancer.

[30]  K. Chaloner,et al.  GB virus C infection and non‐Hodgkin lymphoma: important to know but the jury is out , 2010, International journal of cancer.

[31]  R. Andino,et al.  Rationalizing the development of live attenuated virus vaccines , 2010, Nature Biotechnology.

[32]  J. Stapleton,et al.  GB virus type C interactions with HIV: the role of envelope glycoproteins , 2009, Journal of viral hepatitis.

[33]  Norman L. Letvin,et al.  T-Cell Vaccine Strategies for Human Immunodeficiency Virus, the Virus with a Thousand Faces , 2009, Journal of Virology.

[34]  I. Haro,et al.  Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide. , 2009, The journal of physical chemistry. B.

[35]  Kuan-Teh Jeang,et al.  MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals , 2008, Retrovirology.

[36]  H. Tillmann,et al.  GBV‐C coinfection is negatively correlated to Fas expression and Fas‐mediated apoptosis in HIV‐1 infected patients , 2008, Journal of medical virology.

[37]  Ruslan Medzhitov,et al.  HIV immunology needs a new direction , 2008, Nature.

[38]  V. Reshetnyak,et al.  Hepatitis G virus. , 2008, World journal of gastroenterology.

[39]  A. Widell,et al.  HIV and GB virus C infections seen from the perspective of the vertically coexposed infant. , 2008, The Journal of infectious diseases.

[40]  Tongqing Zhou,et al.  Structural definition of a conserved neutralization epitope on HIV-1 gp120 , 2007, Nature.

[41]  R. K. Sachdeva,et al.  Spontaneous and antigen-induced chemokine production in exposed but uninfected partners of HIV type 1-infected individuals in North India. , 2007, AIDS research and human retroviruses.

[42]  O. Bagasra.  A unified concept of HIV latency , 2006, Expert opinion on biological therapy.

[43]  O. Bagasra,et al.  Role of Micro-RNAs in Regulation of Lentiviral Latency and Persistence , 2006, Applied immunohistochemistry & molecular morphology : AIMM.

[44]  K. Chaloner,et al.  Effect of early and late GB virus C viraemia on survival of HIV‐infected individuals: a meta‐analysis , 2006, HIV medicine.

[45]  J. Stapleton,et al.  GB virus C replicates in primary T and B lymphocytes. , 2006, The Journal of infectious diseases.

[46]  A. Saïb,et al.  A Cellular MicroRNA Mediates Antiviral Defense in Human Cells , 2005, Science.

[47]  H. Schuitemaker,et al.  GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study. , 2005, The Journal of infectious diseases.

[48]  P. Kwong.  Human immunodeficiency virus: Refolding the envelope , 2005, Nature.

[49]  J. Stapleton,et al.  GB Virus Type C: a Beneficial Infection? , 2004, Journal of Clinical Microbiology.

[50]  O. Bagasra,et al.  RNA interference: The molecular immune system , 2004, Journal of Molecular Histology.

[51]  S. Wünschmann,et al.  Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MlP-lα, MIP-1β, and SDF-1 , 2004, The Lancet.

[52]  A. Widell,et al.  GB virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality , 2004, AIDS.

[53]  E. Gouws,et al.  GB virus type C coinfection in HIV-infected African mothers and their infants, KwaZulu Natal, South Africa. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[54]  J. Stapleton.  GB Virus Type C/Hepatitis G Virus , 2003, Seminars in liver disease.

[55]  J. Lama.  The physiological relevance of CD4 receptor down-modulation during HIV infection. , 2003, Current HIV research.

[56]  S. Lindbäck,et al.  No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patients. , 2002, AIDS.

[57]  M. Manns,et al.  GB virus-C infection in patients infected with the human immunodeficiency virus. , 2001, Antiviral research.

[58]  A. Widell,et al.  A case‐control study of transmission routes for GB virus C/hepatitis G virus in Swedish blood donors lacking markers for hepatitis C virus infection , 2001, Vox sanguinis.

[59]  S. Wünschmann,et al.  Effect of coinfection with GB virus C on survival among patients with HIV infection. , 2001, The New England journal of medicine.

[60]  M. Manns,et al.  Infection with GB virus C and reduced mortality among HIV-infected patients. , 2001, The New England journal of medicine.

[61]  B. Walker,et al.  AIDS: Escape from the immune system , 2000, Nature.

[62]  F. Roudot-thoraval,et al.  Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. , 1999, The Journal of infectious diseases.

[63]  M. Manns,et al.  GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? , 1998, The Journal of infectious diseases.

[64]  J. Takamatsu,et al.  Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[65]  T. Leary,et al.  Identification of GB virus C variants by phylogenetic analysis of 5'-untranslated and coding region sequences , 1997, Journal of virology.

[66]  N. Cuceanu,et al.  Discrimination of hepatitis G virus/GBV-C geographical variants by analysis of the 5' non-coding region. , 1997, The Journal of general virology.

[67]  T. Pilot‐Matias,et al.  Sequence and genomic organization of GBV‐C: A novel member of the flaviviridae associated with human non‐A‐E hepatitis , 1996, Journal of medical virology.

[68]  P. Luciw,et al.  Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac). , 1992, AIDS research and human retroviruses.

[69]  R. Parreira,et al.  GB virus C (GBV-C) evolutionary patterns revealed by analyses of reference genomes, E2 and NS5B sequences amplified from viral strains circulating in the Lisbon area (Portugal). , 2012, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[70]  O. Bagasra,et al.  Back to the soil: retroviruses and transposons , 2011 .

[71]  I. Haro,et al.  Assessment of synthetic chimeric multiple antigenic peptides for diagnosis of GB virus C infection. , 2010, Analytical biochemistry.

[72]  H. Tillmann,et al.  GB virus C infection: is there a clinical relevance for patients infected with the human immunodeficiency virus? , 2005, AIDS reviews.

[73]  K. Abe,et al.  Genotyping system of GBV-C/HGV type 1 to type 4 by the polymerase chain reaction using type-specific primers and geographical distribution of viral genotypes. , 2001, Journal of virological methods.

[74]  O. Bagasra.  HIV And Molecular Immunity: Prospects for the AIDS Vaccine , 1999 .